T-786c polymorphism in the endothelial nitric oxide synthase gene is associated with increased risk of coronary artery disease in a Chinese population

Pharmacology

Volumn 85, Issue 4, 2010, Pages 211-216

  Han, Yi ^a   Xu, Weiwei ^b   Zhang, Wen ^b   Liu, Naifeng ^a   Ji, Yong ^b  

^a SOUTHEAST UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Coronary artery disease; Endothelial nitric oxide synthase; Genetic polymorphism

Indexed keywords

CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENOMIC DNA; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CHINESE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DEMOGRAPHY; DNA EXTRACTION; DNA FLANKING REGION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGE FACTORS; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CASE-CONTROL STUDIES; CHINA; CHOLESTEROL, LDL; CORONARY ARTERY DISEASE; FEMALE; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 77649298486     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000275135     Document Type: Article

References (16)

1. Visvikis-Siest S, Marteau JB: Genetic variants predisposing to cardiovascular disease. Curr Opin Lipidol 2006; 17: 139-151.
2. Nakayama M, Yasue H, Yoshimura M: T-786 ] C mutation in the 5 flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis. Am J Cardiol 2000; 86: 628-634.
3. Colombo MG, Paradossi U, Andreassi MG: Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease. Clin Chem 2003; 49: 389-395.
4. Gross SS, Wolin MS: Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 1995; 57: 737-769.
5. Kimura H, Esumi H: Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim Pol 2003; 50: 49-59.
6. Miyamoto Y, Saito Y, Kajiyama N, Yoshimura M, Shimasaki Y, Nakayama M, Kamitani S, Harada M, Ishikawa M, Kuwahara K, Ogawa E, Hamanaka I, Takahashi N, Kaneshige T, Teraoka H, Akamizu T, Azuma N, Yoshimasa Y, Yoshimasa T, Itoh H, Masuda I, Yasue H, Nakao K: Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998; 32: 3-8.
7. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K: T-786 ] C mutation in the 5 - -flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864-2870.
8. De Syllos RW, Sandrim VC, Lisboa HR, Tres GS, Tanus-Santos JE: Endothelial nitric oxide synthase genotype and haplotype are not associated with diabetic retinopathy in diabetes type 2 patients. Nitric Oxide 2006; 15: 417-422.
9. Taverna MJ, Sola A, Guyot-Argenton C, Pacher N, Bruzzo F, Chevalier A, Slama G, Reach G, Selam JL: eNOS4 polymorphism of the endothelial nitric oxide synthase predicts risk for severe diabetic retinopathy. Diabet Med 2002; 19: 240-245.
10. Kawashima S, Yokoyama M: Dysfunction of endothelial nitric oxide synthase and atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 998-1005.
11. Stangl K, Cascorbi I, Laule M, Klein T, Stangl V, Rost S, Wernecke KD, Felix SB, Bindereif A, Baumann G, Roots I: High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery disease. Pharmacogenetics 2000; 10: 133-140.
12. Markus HS, Ruigrok Y, Ali N, Powell JF: Endothelial nitric oxide synthase exon 7 polymorphism, ischemic cerebrovascular disease, and carotid atheroma. Stroke 1998; 29: 1908-1911.
13. Wolff B, Braun C, Schluter C, Grabe HJ, Popowski K, Volzke H, Ludemann J, John U, Cascorbi I: Endothelial nitric oxide synthase Glu(298) ] Asp gene polymorphism, carotid atherosclerosis, and intima-media thickness in a general population sample. Clin Sci (Lond) 2005; 109: 475-481.
14. Hingorani AD, Liang CF, Fatibene J, Lyon A, Monteith S, Parsons A, Haydock S, Hopper RV, Stephens NG, O'Shaughnessy KM, Brown MJ: A common variant of the endothelial nitric oxide synthase (Glu298 ] Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999; 100: 1515-1520.
15. Böger RH, Bode-Böger SM, Brandes RP, Phivthong-ngam L, Böhme M, Nafe R, Mügge A, Frölich JC: Dietary L -arginine reduces the progression of atherosclerosis in cholesterol- fed rabbits. Circulation 1997; 96: 1282-1290.
16. Kauser K, da Cunha V, Fitch R, Mallari C, Rubanyi GM: Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. Am J Physiol 2000; 278:H1679-H1685.